201 related articles for article (PubMed ID: 2453754)
1. Beneficial effects of fenoldopam on systemic and regional hemodynamics in rabbits with congestive heart failure.
Jover BF; McGrath BP
J Cardiovasc Pharmacol; 1988 Apr; 11(4):483-8. PubMed ID: 2453754
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure.
Francis GS; Wilson BC; Rector TS
Am Heart J; 1988 Aug; 116(2 Pt 1):473-9. PubMed ID: 2899970
[TBL] [Abstract][Full Text] [Related]
3. Beneficial acute effects of selective modulation of renal dopamine system by gamma-L-glutamyl-L-dopa in rabbits with congestive heart failure.
Wang ZQ; Way D; Shimizu K; Fong F; Trigg L; McGrath BP
J Cardiovasc Pharmacol; 1993 Jun; 21(6):1004-11. PubMed ID: 7687706
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise.
Krombach RS; Clair MJ; Hendrick JW; Mukherjee R; Houck WV; Hebbar L; Kribbs SB; Dodd MG; Spinale FG
Am J Cardiol; 1999 Aug; 84(4A):3L-15L. PubMed ID: 10480440
[TBL] [Abstract][Full Text] [Related]
5. Intravenous fenoldopam in heart failure: comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprusside.
Young JB; Leon CA; Pratt CM; Kingry C; Taylor AA; Roberts R
Am Heart J; 1988 Feb; 115(2):378-84. PubMed ID: 2893527
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
[TBL] [Abstract][Full Text] [Related]
7. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of volatile anesthesia in rabbits: influence of chronic heart failure and enalaprilat treatment.
Blake DW; Way D; Trigg L; Langton D; McGrath BP
Anesth Analg; 1991 Oct; 73(4):441-8. PubMed ID: 1654754
[TBL] [Abstract][Full Text] [Related]
9. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the renal and pulmonary hemodynamic effects of fenoldopam, dobutamine, dopamine and norepinephrine in the anesthetized dog.
Shebuski RJ; Smith JM; Ruffolo RR
Pharmacology; 1988; 36(1):35-43. PubMed ID: 2893393
[TBL] [Abstract][Full Text] [Related]
12. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
13. Regional blood flow effects of dopexamine versus enalaprilat during propofol anaesthesia in rabbits with experimental chronic heart failure.
Blake DW; Way D; Trigg L; McGrath BP
Cardiovasc Res; 1994 May; 28(5):710-4. PubMed ID: 8025917
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of an oral dopamine receptor agonist (fenoldopam) in patients with congestive heart failure.
Young JB; Leon CA; Pratt CM; Suarez JM; Aronoff RD; Roberts R
J Am Coll Cardiol; 1985 Oct; 6(4):792-6. PubMed ID: 2863295
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular responses to graded treadmill exercise during the development of doxorubicin induced heart failure in rabbits.
Langton D; Jover B; McGrath BP; Ludbrook J
Cardiovasc Res; 1990 Dec; 24(12):959-68. PubMed ID: 2097062
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
Leier CV; Binkley PF; Carpenter J; Randolph PH; Unverferth DV
Am J Cardiol; 1988 Jul; 62(1):94-9. PubMed ID: 2898209
[TBL] [Abstract][Full Text] [Related]
17. Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failure.
Munger MA; Benotti JR; Green JA; Jarvis RC; Nara AR; McCue JE; Pospisil RA; Kasmer RJ
Am J Cardiol; 1990 Jan; 65(3):206-10. PubMed ID: 1967511
[TBL] [Abstract][Full Text] [Related]
18. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure.
Rademaker MT; Charles CJ; Lewis LK; Yandle TG; Cooper GJ; Coy DH; Richards AM; Nicholls MG
Circulation; 1997 Sep; 96(6):1983-90. PubMed ID: 9323090
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.
Glück Z; Jossen L; Weidmann P; Gnädinger MP; Peheim E
Hypertension; 1987 Jul; 10(1):43-54. PubMed ID: 2885268
[TBL] [Abstract][Full Text] [Related]
20. Regional distribution of the cardiac output and renal responses to atrial natriuretic peptide infusion in rabbits with congestive heart failure.
Langton D; Jover BF; Trigg L; Fullerton M; Blake DW; McGrath BP
Clin Exp Pharmacol Physiol; 1989 Dec; 16(12):939-51. PubMed ID: 2532997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
